The Best Growth Stocks to Buy in 2026: Your Essential Portfolio Guide

The stock market’s impressive run shows no signs of stopping. The S&P 500 has delivered double-digit returns in back-to-back years, with artificial intelligence emerging as the primary growth engine. As we advance through 2026, identifying the best growth stocks to buy becomes increasingly important for investors seeking both capital appreciation and stability. This curated selection of 10 companies spans multiple industries and growth catalysts, offering a balanced approach to building a resilient investment portfolio.

Strategic Investment Themes in 2026

These best growth stocks to buy share common characteristics: they’re leaders in their sectors, exposed to transformative trends like AI adoption, and positioned for sustained revenue growth. Rather than relying on outdated metrics alone, today’s investors should consider how these companies are adapting to technological change while maintaining financial stability. The following portfolio balances aggressive growth opportunities with defensive characteristics, providing a comprehensive investment framework for the year ahead.

Technology & AI Innovation: Powerhouse Growth Stocks

Nvidia - The AI Infrastructure Cornerstone

Nvidia (NASDAQ: NVDA) remains the linchpin of AI infrastructure spending. As one of the best growth stocks to buy for tech-focused portfolios, the company continues to benefit from enterprises building out AI capabilities. The semiconductor designer’s earnings trajectory suggests significant runway ahead—AI infrastructure spending could exceed trillions of dollars over the coming years. Unlike cyclical tech plays, Nvidia’s positioning in foundational AI technology suggests durability in its growth story.

CoreWeave - Emerging Infrastructure Winner

CoreWeave (NASDAQ: CRWV) exemplifies the type of emerging growth stock worth monitoring. Since its market debut in early 2024, the company has demonstrated strong demand for AI compute capacity. By providing high-powered computing resources to AI customers, CoreWeave taps into persistent infrastructure demand that will likely accelerate through 2026 and beyond. For aggressive growth-focused investors, this represents a compelling opportunity despite its volatility.

Meta Platforms - Cheap Growth with AI Leverage

Meta Platforms (NASDAQ: META) offers perhaps the most attractive valuation among established tech leaders. Trading at 26x forward earnings, the company appears undervalued relative to its earnings growth prospects. Beyond its core social media business, Meta’s substantial AI investments—including development of large language models and virtual assistants—position it as both a cheap growth stock and a pure-play AI transformation story.

Healthcare & Pharmaceutical Innovation

Eli Lilly - Weight Loss Drug Dominance

Eli Lilly (NYSE: LLY) represents a compelling combination of current growth and future potential. The blockbuster success of Mounjaro (for type 2 diabetes) and Zepbound (for weight loss) has already transformed the company’s revenue trajectory. With oral weight loss candidates like orforglipron advancing through clinical trials, Eli Lilly exemplifies how best growth stocks to buy combine proven cash generation with exciting pipeline potential. This positions the company as both a growth and income-generating investment.

Viking Therapeutics - Opportunity in Competitive Markets

Viking Therapeutics (NASDAQ: VKTX) demonstrates that the weight loss drug market has room for multiple winners. With candidates in both phase 3 and phase 2 trials showing promising results, the company is positioned to capture meaningful market share alongside established players. This mid-stage biotech stock appeals to growth investors willing to accept higher risk for potential outsized returns.

Abbott Laboratories - Stability with Growth

Abbott Laboratories (NYSE: ABT) anchors the defensive portion of a balanced growth portfolio. The company’s 50-year track record of consecutive dividend increases—a Dividend King designation—demonstrates management commitment to shareholder returns. Abbott’s diversified operations spanning medical devices, diagnostics, nutrition, and pharmaceuticals provide stability, while category-leading products like FreeStyle Libre and Ensure support ongoing growth. It represents one of the best growth stocks to buy for investors prioritizing compounding returns and downside protection.

Healthcare Services & Insurance

UnitedHealth Group - Recovery Play

UnitedHealth Group (NYSE: UNH) as the nation’s largest health insurer faces meaningful challenges, but recent actions suggest meaningful progress. The company’s efforts to address cost pressures through plan optimization and AI-driven efficiency improvements are already yielding positive results, evidenced by recent guidance increases. At 20x forward earnings, the stock offers compelling valuation for a company with clear visibility on profitability recovery.

Consumer & E-Commerce Innovation

American Express - Premium Customer Stickiness

American Express (NYSE: AXP) maintains competitive advantages in the high-income payment card market where customer loyalty runs deep. The company’s growth in younger demographics—with Millennials and Gen-Z comprising 64% of new accounts in recent periods—suggests successful market penetration beyond traditional affluent segments. This represents growth from an established market leader with proven pricing power and customer economics.

Chewy - Subscription Model Excellence

Chewy (NYSE: CHWY) demonstrates how best growth stocks to buy in consumer sectors leverage sticky subscription models. The company’s AutoShip program, accounting for over 80% of net sales, provides predictable revenue visibility and exceptional customer retention. Operating profitably while maintaining zero debt, Chewy combines growth with financial strength—an increasingly rare combination that appeals to quality-focused investors.

Amazon - Diversified Growth Engine

Amazon (NASDAQ: AMZN) represents the ultimate diversified growth stock. The company’s established market leadership in both e-commerce and cloud computing provides a proven foundation, while accelerating AI integration across these businesses unlocks additional growth. AWS alone generates over $132 billion in annual revenue run rate, with AI already driving meaningful efficiency gains. At 32x forward earnings estimates, the stock reflects reasonable valuation for a company demonstrating durable competitive advantages and multiple growth vectors.

Building Your 2026 Portfolio

The best growth stocks to buy share a common thread: they combine specific growth catalysts with defensible competitive positions. This portfolio spans artificial intelligence infrastructure, pharmaceutical innovation, financial services, healthcare delivery, and consumer technology—providing genuine diversification across secular growth trends.

Success in 2026 requires moving beyond simple “growth” or “value” categorization. The stocks outlined above represent companies with sustainable advantages, proven management execution, and catalysts supporting continued share price appreciation. Whether you prioritize aggressive growth or balanced returns, these selections offer entry points into some of the market’s most important transformations while maintaining the financial discipline that separates long-term winners from speculative plays.